Keyphrases
Cytotoxic T Lymphocytes
100%
Leukemia
100%
FMS-like Tyrosine Kinase 3 (FLT3)
100%
Acute Myeloid Leukemia
36%
Leukemia-associated Antigen
36%
Cytotoxic T Cells
27%
FMS-like Tyrosine Kinase 3 Internal Tandem Duplication
27%
T Cell Clone
18%
PR-3
18%
Survivin
18%
RHAMM
18%
Expression Pattern
9%
Multiple Genes
9%
Antigen Expression
9%
Myeloid Cells
9%
Myeloid Dendritic Cells
9%
Constitutive Activation
9%
BCR-ABL
9%
Leukemia Patients
9%
Leukemia Cell Lines
9%
PRAME
9%
Specific Immunotherapy
9%
Myeloid Leukemia
9%
T Cell Recognition
9%
Constitutively Active
9%
Acute Myeloid Leukemia Cells
9%
Internal Tandem Duplication
9%
Abl Kinase
9%
Juxtamembrane Domain
9%
Promising Target
9%
Medicine and Dentistry
Cytotoxic T-Cell
100%
FMS-Like Tyrosine Kinase 3
100%
Leukemia
100%
Acute Myeloid Leukemia
30%
Phosphotransferase
15%
Survivin
15%
down Regulation
7%
Myeloid Cell
7%
Antigen Specificity
7%
Antigen Expression
7%
Myeloid Dendritic Cell
7%
Upregulation
7%
Myeloid Leukemia
7%
Abelson Kinase
7%
Acute Myeloid Leukemia Cell Line
7%
Immunotherapy
7%
Biochemistry, Genetics and Molecular Biology
FMS-Like Tyrosine Kinase 3
100%
Cytotoxic T Cell
100%
Myeloid
66%
Wild Type
33%
Phosphotransferase
25%
Kinase
25%
Cell Clone
16%
Survivin
16%
FMS-like Tyrosine Kinase 3 Ligand
8%
Antigen Specificity
8%
down Regulation
8%
Upregulation
8%
Antigen Expression
8%
Dendritic Cell
8%
Immunology and Microbiology
Cytotoxic T Cell
100%
Tyrosine
100%
Myeloid
46%
Wild Type
30%
Cell Clone
15%
Acute Myeloid Leukemia Cell Line
7%
Antigen Specificity
7%
down Regulation
7%
Upregulation
7%
Antigen Expression
7%
Myeloid Dendritic Cell
7%
Immunotherapy
7%
Pharmacology, Toxicology and Pharmaceutical Science
Leukemia
100%
Protein Kinase Fer
100%
Acute Myeloid Leukemia
38%
Phosphotransferase
15%
Survivin
15%
Abelson Kinase
7%
Immunotherapy
7%
Myeloid Leukemia
7%